IKT – inhibikase therapeutics, inc. (US:NASDAQ)

Sec Filings

Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Munshi Amit
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: ADAR1 Capital Management, LLC
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: Fairmount Funds Management LLC
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com